Measuring antidepressant prescribing practice in a health care system using administrative data: implications for quality measurement and improvement.
暂无分享,去创建一个
[1] A. Stewart,et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. , 1989, JAMA.
[2] J. Amsterdam,et al. Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. , 1998, The American journal of psychiatry.
[3] S. Leatherman,et al. Using Claims Data for Epidemiologic Research: The Concordance of Claims-Based Criteria With the Medical Record and Patient Survey for Identifying a Hypertensive Population , 1993, Medical care.
[4] Alan D. Lopez,et al. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.
[5] K. Wells,et al. How can care for depression become more cost-effective? , 1995, JAMA.
[6] Wayne Katon,et al. Adequacy and Duration of Antidepressant Treatment in Primary Care , 1992, Medical care.
[7] E H Wagner,et al. Patterns of antidepressant use in community practice. , 1993, General hospital psychiatry.
[8] C. Sennett. Perspective: Moving Ahead, Measure By Measure , 1998 .
[9] A. Rush,et al. Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. , 1998, Archives of general psychiatry.
[10] Compliance and quality of response are major contributors to cost‐effective antidepressant therapy , 1994 .
[11] D. Kupfer,et al. Five-year outcome for maintenance therapies in recurrent depression. , 1990, Archives of general psychiatry.
[12] W. Katon,et al. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants. , 1996, JAMA.
[13] T. Croghan,et al. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. , 1998, Archives of general psychiatry.
[14] L. George,et al. Depression, disability days, and days lost from work in a prospective epidemiologic survey. , 1990, JAMA.
[15] D M Eddy,et al. Performance measurement: problems and solutions. , 1998, Health affairs.
[16] E. Berndt,et al. The economic burden of depression in 1990. , 1993, The Journal of clinical psychiatry.
[17] I. Anderson,et al. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis , 1995, BMJ.
[18] M. Thase,et al. Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. , 1998, JAMA.
[19] G. Engquist,et al. Course of antidepressant treatment with tricyclic versus selective serotonin reuptake inhibitor agents: a comparison in managed care and fee-for-service environments. , 1997, The American journal of managed care.
[20] K. Wells,et al. Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the medical outcomes study. , 1994, The American journal of psychiatry.